Cargando…

Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism

We investigated the influence of cannabidiol (CBD) on blood pressure (BP) and heart rate (HR) in spontaneously (SHR) and deoxycorticosterone (DOCA-salt) hypertensive rats. Hypertension was connected with increases in cardiac and plasma markers of lipid peroxidation in both models, whereas cardiac en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remiszewski, Patryk, Jarocka-Karpowicz, Iwona, Biernacki, Michał, Jastrząb, Anna, Schlicker, Eberhard, Toczek, Marek, Harasim-Symbor, Ewa, Pędzińska-Betiuk, Anna, Malinowska, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072941/ https://www.ncbi.nlm.nih.gov/pubmed/32075117 http://dx.doi.org/10.3390/ijms21041295

Ejemplares similares

Cannabinoids in arterial, pulmonary and portal hypertension – mechanisms of action and potential therapeutic significance
por: Malinowska, Barbara, et al.
Publicado: (2018)

Effects of the peripheral CB(1) receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
por: Remiszewski, Patryk, et al.
Publicado: (2022)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
por: Weresa, Jolanta, et al.
Publicado: (2022)

Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
por: Toczek, Marek, et al.
Publicado: (2023)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris
por: Jarocka-Karpowicz, Iwona, et al.
Publicado: (2020)

Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT(3) Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
por: Kossakowski, Rafał, et al.
Publicado: (2019)

Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol
por: Biernacki, Michał, et al.
Publicado: (2021)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
por: Harasim-Symbor, Ewa, et al.
Publicado: (2020)

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

The Origin and Biomedical Relevance of Cannabigerol
por: Jastrząb, Anna, et al.
Publicado: (2022)

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
por: Atalay, Sinemyiz, et al.
Publicado: (2019)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)

The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension
por: Biernacki, Michał, et al.
Publicado: (2018)

Exogenous Antioxidants Impact on UV-Induced Changes in Membrane Phospholipids and the Effectiveness of the Endocannabinoid System in Human Skin Cells
por: Gęgotek, Agnieszka, et al.
Publicado: (2021)

The Effect of Sea Buckthorn (Hippophae rhamnoides L.) Seed Oil on UV-Induced Changes in Lipid Metabolism of Human Skin Cells
por: Gęgotek, Agnieszka, et al.
Publicado: (2018)

Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension
por: Remiszewski, Patryk, et al.
Publicado: (2022)

Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023)

Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

Enhancing Endocannabinoid Control of Stress with Cannabidiol
por: Henson, Jeremy D., et al.
Publicado: (2021)

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
por: Berk, Klaudia, et al.
Publicado: (2022)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2021)

CB(1) receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
por: Grzęda, Emilia, et al.
Publicado: (2016)

Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer
por: Modzelewska, Beata, et al.
Publicado: (2016)

Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
por: Jastrząb, Anna, et al.
Publicado: (2019)

Metabolic Response to Tick-Borne Encephalitis Virus Infection and Bacterial Co-Infections
por: Dobrzyńska, Marta, et al.
Publicado: (2022)

Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention
por: Scharf, Eugene L.
Publicado: (2017)

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
por: Chye, Yann, et al.
Publicado: (2019)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
por: Rabino, Martina, et al.
Publicado: (2021)

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health
por: Capodice, Jillian L., et al.
Publicado: (2021)

The Impact of Severe COVID-19 on Plasma Antioxidants
por: Žarković, Neven, et al.
Publicado: (2022)

Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Krzyżewska, Anna, et al.
Publicado: (2022)

Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients
por: Ambrożewicz, Ewa, et al.
Publicado: (2018)

Cross-Talk between CB(1), AT(1), AT(2) and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive Controls
por: Mińczuk, Krzysztof, et al.
Publicado: (2022)

Polypharmacology: promises and new drugs in 2022
por: Ryszkiewicz, Piotr, et al.
Publicado: (2023)

How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
por: Dziemitko, Sylwia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_penjc7j5kdpsvegrjql79tl680